New York, NY -- (SBWIRE) -- 03/27/2013 -- Opexa Therapeutics Inc. (NASDAQ:OPXA) traded at $ 2.61 in the last session, which is +0.50 (23.70%). The stock has a Range of 2.15 - 2.72. The stock has a 52 week low and high of 1.07 - 5.19 respectively. The stock has a Market Cap of 15.04M. The stock traded a volume of 5.20M. The stock has a 30 day average volume of 398,617.00.
Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in developing personalized cellular therapies with the potential to treat illnesses, including multiple sclerosis (MS). These therapies are based on its T-cell technology.
Find out when could be the best moment to trade OPXA here:
American Apparel, Inc. (NYSE: APP), a vertically integrated manufacturer, distributor, and retailer of branded fashion basic apparel, announced earlier this month, preliminary sales for the month ended February 28, 2013, and reported that comparable sales increased 6%, including a 3% increase in comparable store sales for its retail store channel and a 28% increase in net sales for its online channel.
Wholesale net sales decreased 2% for the month of February primarily due to one less wholesale shipping day in 2013 (February 2012 had 29 days). If adjusted to eliminate the effect of the extra shipping day in 2012, the Company estimates wholesale net sales would have shown an increase of approximately 4%. On a preliminary basis, total net sales for February 2013 were $42.1 million.
“February represents our 21st consecutive month of positive comparable store growth,” said DovCharney, Chairman and Chief Executive of American Apparel, Inc.
Find out more on APP here:
Stockreportdaily.com issues momentum alerts on stocks that can provide gains to day traders. Stockreportdaily.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. Stockreportdaily.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Stockreportdaily.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Stockreportdaily.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Stockreportdaily.com
Stockreportdaily.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Stockreportdaily.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.Stockreportdaily.com/disclaimer/
Stock Report Daily